Loading…
Loading…
EQUITY / NASDAQ · XNMS
Translational Development Acquisition Corp.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗10.82 USD · 0%
Observed: Oct 2, 2026, 7:44 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 10.82 USD · Volume 9,227
20 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -661,050 USD | -221,127 USD | — |
| Net income | 946,982 USD | 1,623,342 USD | -41.66% |
| Cash and cash equivalents | 85,877 USD | — | — |
| Total liabilities | 7,789,050 USD | — | — |
| Total equity | -7,684,319 USD | -6,166,105 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 85,877 USD | — | — | 29,787 USD | 29,787 USD | 47,150 USD | — | — |
| Net incomeIncome statement | 946,982 USD | 2,279,779 USD | 1,332,797 USD | — | 6,362,427 USD | 1,660,122 USD | 4,766,538 USD | 1,623,342 USD |
| Operating profitIncome statement | -661,050 USD | -942,211 USD | — | — | -944,538 USD | -213,658 USD | -782,193 USD | -221,127 USD |
| Total assetsBalance sheet | 157,366,598 USD | — | — | 181,696,776 USD | 181,696,776 USD | 179,979,659 USD | — | — |
| Total equityBalance sheet | -7,684,319 USD | — | -6,823,269 USD | -6,542,108 USD | -6,542,108 USD | -6,379,763 USD | — | -6,166,105 USD |
| Total liabilitiesBalance sheet | 7,789,050 USD | — | — | 6,581,573 USD | 6,581,573 USD | 6,460,345 USD | — | — |
| Financing cash flowCash flow statement | — | -26,917,434 USD | — | — | 200,000 USD | — | 100,000 USD | — |
| Investing cash flowCash flow statement | — | 27,617,434 USD | — | — | — | — | — | — |
| Operating cash flowCash flow statement | — | -643,910 USD | — | — | -608,387 USD | — | -491,024 USD | — |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/30/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 08/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.